Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality

NACompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

October 5, 2021

Study Completion Date

October 5, 2021

Conditions
Iron Deficiency
Interventions
DRUG

Iron-dextran

Approved for clinical use: 1-gram dose IV - diluted in 500 mL, one pint normal saline.

DRUG

Saline

Salt water IV - 500 mL, one pint normal saline.

PROCEDURE

Blood Donation

Standard process of collecting and storing blood and blood components (approximately 450 mL, or a pint of blood). Following donation, the blood will be leukoreduced, packed, and stored in AS-3 solution.

PROCEDURE

24-hour PTR

"The way the FDA determines how good blood is for transfusion is called a radioactive 51-Chromium 24-hour post-transfusion red cell recovery study. The purpose is to measure how many of the transfused red cells are still in circulation (being pumped by the heart through blood vessels) 24 hours after transfusion. In order to measure the percent of red cells that are still in circulation, a small amount of the donated blood will be radioactively labeled. This will be infused in one arm and then blood will be collected from the other arm at different time points to measure how much of the transfused red cells are still in circulation."

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

New York Blood Center

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Columbia University

OTHER

NCT02889133 - Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality | Biotech Hunter | Biotech Hunter